Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia

NCT00459212

Conditions: Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +40 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT00082966

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, Adult Nodular Sclerosis Hodgkin Lymphoma, +10 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Predictors of Lymphedema Following Breast Cancer Surgery

NCT00202046

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: North Memorial Medical Center Minneapolis, Minnesota, United States

Fairview University Minneapolis, Minnesota, United States

Park Nicollet Institute Saint Louis Park, Minnesota, United States

View Trial Details

Completed

Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma

NCT01276717

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Rochester Rochester, New York, United States

Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab

NCT01123356

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

Greenville Hospital System Greenville, South Carolina, United States

View Trial Details

Completed

MELT - MRI Evaluation of Lymphoma Treatment

NCT01459224

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations: University College London Hospital (UCLH) London, United Kingdom

View Trial Details

Completed

Mozobil for Autologous Stem Cell Mobilization

NCT01164345

Conditions: Autologous Stem Cell Transplantation, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Chaim Sheba Medical Center Tel Litwinsky, Israel

View Trial Details

Completed

Doxycycline In Lymphangioleiomyomatosis (LAM)

NCT00989742

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Nottingham University Hospitals Nottingham, United Kingdom

View Trial Details

Completed

Tofacitinib Ointment For Chronic Plaque Psoriasis

NCT01831466

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
Locations: Burke Pharmaceutical Research Hot Springs, Arkansas, United States

Bakersfield Dermatology and Skin Cancer Medical Center Bakersfield, California, United States

UC Irvine Dermatology Research Irvine, California, United States

Dermatology Research Associates Los Angeles, California, United States

View all 54 locations

View Trial Details

Completed

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

NCT01321346

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +20 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Miami Cancer Center Miami, Florida, United States

View all 20 locations

View Trial Details